Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-017572)

Filing Details

Accession Number:: 0001209191-21-017572
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-03 21:05:17
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-03 21:05:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533040	Phio Pharmaceuticals Corp.	PHIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792987	L Robert Ferrara	C/O Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough MA 01752		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2021-03-01	10,000	$0.00	12,318	No	4	A	Direct
Common Stock, $0.0001 Par Value	Acquisiton	2021-03-03	682	$3.15	13,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Footnotes

Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.